Sort
30,917 grants matching “tumor microenvironment”
Chemoprevention and mechanisms of obesity-promoted pancreatic adenocarcinoma
$1,088,453Guido Erwin Michael Eibl · University Of California Los Angeles · P01 · FY2024 · CA
A Phase IIa Study of rHuIL-12 as an Immunotherapy and Radiomitigator for CTCL Patients Receiving Radiotherapy
$1,088,333Lena A. Basile · Neumedicines, Inc. · R44 · FY2015 · CA
Modulation of Therapeutic Response
$1,088,014James Mitchell · Division Of Clinical Sciences - Nci · ZIA · FY2017 · CA
Astrocytic Cancers: How, When, Where?
$1,087,426Terry A Van Dyke · Univ Of North Carolina Chapel Hill · U01 · FY2007 · CA
Astrocytic Cancers: How, When, Where?
$1,087,330Terry A Van Dyke · Univ Of North Carolina Chapel Hill · U01 · FY2006 · CA
CHARACTERIZATION OF THE TUMOR MICROENVIRONMENT TO BUILD NOVEL STRATEGIES FOR PREVENTION AND TREATMENT OF CANCER
$1,086,497Sunnybay Biotech · · FY2020 · Defense Health Agency
Signal Transduction Events and the Regulation of Cell Growth
$1,085,526Jane B Trepel · Division Of Clinical Sciences - Nci · ZIC · FY2023 · CA
Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides
$1,085,319Dennis Klinman · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
The Role of the Microenvironment in Barrett's Esophagus
$1,085,045Timothy Cragin Wang · Columbia University Health Sciences · U54 · FY2018 · CA
Functional Genomics of Sarcoma
$1,084,890Paul S. Meltzer · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Pacritinib in rel/refr T-cell lymphomas
$1,084,365Ryan A Wilcox · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
Genetically Engineered Mouse Models to Study RTK Function in Melanoma
$1,082,439Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Mentoring Translational Researchers in Louisiana
$1,082,097Augusto C Ochoa · Lsu Health Sciences Center · P30 · FY2016 · GM
Development of new antibody-based cancer therapies
$1,081,995Mitchell Ho · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
The Unfolded Protein Response in Cancer
$1,081,511Constantinos Koumenis · University Of Pennsylvania · P01 · FY2016 · CA
Translational Research Program in Colorectal Cancer Disparities
$1,081,347Ulrike Peters · Fred Hutchinson Cancer Center · P20 · FY2022 · CA
Intravesical Immunotherapy of Spontaneous Canine Invasive Urothelial Carcinoma
$1,081,084David Zaharoff · North Carolina State University Raleigh · U01 · FY2025 · CA
Immune Escape in Human Cancer: Mechanisms and Therapeutic Implications
$1,081,004Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · P01 · FY2007 · CA
Astrocytic Cancers: How, When, Where?
$1,080,550University Of North Carolina Chapel Hill · U01 · FY2005 · CA
The Role of the Integrated Stress Response in Cancer
$1,080,107Constantinos Koumenis · University Of Pennsylvania · P01 · FY2020 · CA
BAY AREA & ANDERSON TEAM AGAINST ACQUIRED RESISTANCE - U54 PROGRAM (BAATAAR-UP)
$1,079,739Trever G Bivona · University Of California, San Francisco · U54 · FY2025 · CA
Developing Novel Therapies for High Risk Pediatric Cancers
$1,079,318Javed Khan · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Design and Utility of Novel Proteinaceous Biomaterials
$1,079,293Joel Schneider · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Molecular Cytogenetics of Solid Tumors
$1,078,567Nicolae Popescu · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Cancer Prevention-Interception Against MGUS Progression
$1,078,336Yong Li · Baylor College Of Medicine · U54 · FY2024 · CA